Early research (Phase 1)Study completedNCT00478725What this trial is testingPart A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034Who this might be right forCarcinoma, Renal Cell GlaxoSmithKline 10
Early research (Phase 1)Study completedNCT02894385What this trial is testingEffect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)Who this might be right forPharmacokineticsHepatic InsufficiencyRenal Insufficiency Bayer 29
Early research (Phase 1)Study completedNCT00824590What this trial is testingA Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal FunctionWho this might be right forAlzheimer's DiseaseHuntington's Disease Pfizer 20
Early research (Phase 1)Study completedNCT00750620What this trial is testingA Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal ImpairmentWho this might be right forRenal Impairment Astellas Pharma Inc 33
Early research (Phase 1)Ended earlyNCT05878704What this trial is testingStudy of GBT021601 in Participants With Renal ImpairmentWho this might be right forRenal Impairment Pfizer 8
Testing effectiveness (Phase 2)Study completedNCT01033123What this trial is testingA Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian CancerWho this might be right forOvarian Cancer Sanofi 41
Testing effectiveness (Phase 2)UnknownNCT05259540What this trial is testingEffect of Compound Kushen Injection Combined With Pabolizumab in the Treatment of Cervical AdenocarcinomaWho this might be right forCervical Cancer Women's Hospital School Of Medicine Zhejiang University 42
Early research (Phase 1)Looking for participantsNCT07623369What this trial is testingA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forSolid TumorNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Huahui Health 299
Not applicableStudy completedNCT03978741What this trial is testingStudy Evaluating the Efficacy and Safety of Yoni.Fit in Women With Stress Urinary IncontinenceWho this might be right forUrinary Incontinence Watkins Conti Products. Inc. 80
Testing effectiveness (Phase 2)WithdrawnNCT06247241What this trial is testingA Phase 2a Study To Evaluate VMB-100 In Females With Stress Urinary IncontinenceWho this might be right forStress Urinary Incontinence Versameb AG
Testing effectiveness (Phase 2)UnknownNCT04387500What this trial is testingSintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell CarcinomaWho this might be right forCarcinoma, Renal CellFumarate Hydratase DeficiencyImmunotherapy West China Hospital 41
Early research (Phase 1)Study completedNCT01367509What this trial is testingPharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal FunctionWho this might be right forRenal Impairment Bausch Health Americas, Inc. 32
Early research (Phase 1)Not Yet RecruitingNCT07793162What this trial is testingA Phase Ia Trial Comparing the Pharmacokinetics/Pharmacodynamics, Safety, and Preliminary Efficacy of HHK001 and Enantone in Patients With EndometriosisWho this might be right forEndometriosis The Third Xiangya Hospital of Central South University 20
Testing effectiveness (Phase 2)Study completedNCT04340362What this trial is testingPhase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental GlomerulosclerosisWho this might be right forGlomerulosclerosis, Focal Segmental Vertex Pharmaceuticals Incorporated 16
Testing effectiveness (Phase 2)Ended earlyNCT03367871What this trial is testingCombination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical CancerWho this might be right forCervical Cancer University of Miami 17
Testing effectiveness (Phase 2)UnknownNCT05606263What this trial is testingEfficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical CancerWho this might be right forCervical Cancer Xi'an Jiaotong University 55
Early research (Phase 1)Ended earlyNCT04726332What this trial is testingStudy of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)Who this might be right forNeoplasm MalignantEpithelial Ovarian CancerTriple Negative Breast Cancer+2 more Exelixis 52
Not applicableUnknownNCT04444206What this trial is testingPrevention of Preterm Birth by Screening of the Consistency Index and Length of the Uterine Cervix in Women With a Single PregnancyWho this might be right forPregnancy, High RiskPreterm BirthCervix; Pregnancy+3 more University of Campania Luigi Vanvitelli 500
Large-scale testing (Phase 3)Study completedNCT03070899What this trial is testingEfficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine FibroidsWho this might be right forUterine FibroidsHeavy Menstrual Bleeding ObsEva SA 526
Testing effectiveness (Phase 2)UnknownNCT03912402What this trial is testingEfficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)Who this might be right forCervical CancerCervical Cancer MetastaticCervical Cancer Recurrent Biocad 49